Episodes

  • Vladimir Bulovic, Director of MIT.nano featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

    IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

    We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $1B.

    IndieBio is a member of SOSV a $650M global fund focused on lasting impact.

  • Emily Leproust, CEO of Twist Biosciences featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

    IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

    We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $1B.

    IndieBio is a member of SOSV a $650M global fund focused on lasting impact.

    Follow on www.twitter.com/indbio

  • Missing episodes?

    Click here to refresh the feed.

  • Peter Brannen, Author of The Ends of the World & Science Journalist featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

    IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

    We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $1B.

    IndieBio is a member of SOSV a $650M global fund focused on lasting impact.

    Follow on www.twitter.com/indbio

  • Jonathan Foley, Executive Director of Project Drawdown featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

    IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

    We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $1B.

    IndieBio is a member of SOSV a $650M global fund focused on lasting impact.

    Follow on www.twitter.com/indbio

  • Jamie Wheal , Executive Director of The Flow Genome Project & Co-Author of "Stealing Fire" featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

    IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

    We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 94 companies have graduated from the program, with a combined current valuation of over $1B.

    IndieBio is a member of SOSV a $500M global fund focused on lasting impact.

    Follow on www.twitter.com/indbio

    https://www.facebook.com/indiebio/

  • Rick Doblin, Founder and Executive Director of Multidisciplinary Association for Psychedelic Studies (MAPS) featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

    IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

    We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $1B.

    IndieBio is a member of SOSV a $650M global fund focused on lasting impact.

    Follow on www.twitter.com/indbio

  • Melanie Matheu, C.E.O. & Founder of Prellis Biologics featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

    IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

    We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $1B.

    IndieBio is a member of SOSV a $650M global fund focused on lasting impact.

    Follow on www.twitter.com/indbio

  • Maria Soloveychik, co-founder and CEO of SyntheX featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

    IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

    We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $1B.

    IndieBio is a member of SOSV a $650M global fund focused on lasting impact.

    Follow on www.twitter.com/indbio

  • Hyunjun Park, co-founder and CEO of Catalog featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

    IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

    We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $1B.

    IndieBio is a member of SOSV a $650M global fund focused on lasting impact.

    Follow on www.twitter.com/indbio

  • Darrin Crisitello, Vice President, Global Sales, Marketing, and Operations at Color Genomics & IndieBio Adjunct Partner featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

    IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

    We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $1B.

    IndieBio is a member of SOSV a $650M global fund focused on lasting impact.

    Follow on www.twitter.com/indbio

  • Po Bronson, Futurist & 7x NY Times Best Selling Author featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

    IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

    We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $1B.

    IndieBio is a member of SOSV a $650M global fund focused on lasting impact.

    Follow on www.twitter.com/indbio

  • Dariush Mozaffarian, Dean of Tufts Friedman School of Nutrition Science and Policy, featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

    IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

    We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $1B.

    IndieBio is a member of SOSV a $650M global fund focused on lasting impact.

    Follow on www.twitter.com/indbio

  • Joon Yun, President and Managing Partner of Palo Alto Investors, Founder of the Palo Alto Prize for Longevity, featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

    IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

    We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $1B.

    IndieBio is a member of SOSV a $650M global fund focused on lasting impact.

    Follow on www.twitter.com/indbio

  • Ursheet Parikh, Partner at Mayfield Fund, entrepreneur and investor featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

    IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

    We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $1B.

    IndieBio is a member of SOSV a $650M global fund focused on lasting impact.

    Follow on www.twitter.com/indbio

  • Steve Blank, Entrepreneur and Founder of the Lean Startup movement featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

    IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

    We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $1B.

    IndieBio is a member of SOSV a $650M global fund focused on lasting impact.

    Follow on www.twitter.com/indbio

  • David Eagleman, Neuroscientist, Author & Founder of NeoSensorgy featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

    IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

    We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $1B.

    IndieBio is a member of SOSV a $650M global fund focused on lasting impact.

    Follow on www.twitter.com/indbio

  • Tim Lu of Senti Biosciences featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

    IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

    We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $1B.

    IndieBio is a member of SOSV a $650M global fund focused on lasting impact.

    Follow on www.twitter.com/indbio